fda activity for nivolumab, t-vec in melanoma, new lung cancer findings, mds findings, and more
Published 9 years ago • 1.3K plays • Length 8:01Download video MP4
Download video MP3
Similar videos
-
1:34
fda approves frontline nivolumab for advanced melanoma
-
4:22
nivolumab in non-small cell lung cancer
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
5:00
fda d.i.s.c.o.: nivolumab for adjuvant treatment of patients with melanoma
-
5:21
fda approvals in cll and all, nda accepted in melanoma, and more
-
6:56
fda approves tas-102, nivolumab breakthrough in rcc, two priority reviews, and more
-
1:01
dr. heymach on nivolumab for lung cancer
-
1:49
dr. luke on the fda approval of adjuvant nivolumab in melanoma
-
1:24
dr. ernstoff discusses nivolumab and ipilimumab in advanced melanoma
-
2:05
dr. jeffrey weber explores nivolumab in advanced melanoma
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
6:19
should you treat melanoma with nivolumab and relatlimab (opdualag)?
-
1:29
dr. robert andtbacka reviews the efficacy of t-vec in advanced melanoma
-
1:20
pixatimod and nivolumab in metastatic melanoma, nsclc and mss crc
-
1:55
fda approves opdivo® (nivolumab) in the united states
-
8:43
future role of checkpoint inhibitors in melanoma
-
48:44
fda-mra approaches to neoadjuvant treatment in melanoma: session 2
-
0:46
fda approves capmatinib for advanced lung cancer